This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.
For eight years, Ntombi, who worked at a health organization in Johannesburg, helped caregivers tell their HIV-positive children about the disease they had. She made sure those children stayed on the medications that suppressed the virus. She visited her patients at their homes to get them any food and financial support they needed. But then, one day in late January, she was told she had to stop her work, immediately.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. The following trends not only shaped the sector then but also set the stage for the future of pharma manufacturing, both in India and globally.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
New results from a trial investigating a synthetic form of psilocybin, administered with psychological support, showed that it extended the time participants with treatment-resistant depression (TRD) were free from depressive symptoms. A single 25mg dose of COMP360 psilocybin had benefit over smaller 1mg and 10mg doses in the 52-week COMP004 follow-up study to the Phase IIb (COMP001 and COMP003) trials.
TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical. In a recent filing with the Securities and Exchange Commission, Zynex revealed that the government payer — which represents up to a quarter of Zynex’s annual revenue — was suspending payments as it reviewed prior claims.
251
251
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management device maker Zynex Medical. In a recent filing with the Securities and Exchange Commission, Zynex revealed that the government payer — which represents up to a quarter of Zynex’s annual revenue — was suspending payments as it reviewed prior claims.
Eli Lilly and Company (India) announced the launch of Mounjaro in single-dose vial presentation following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c
Unlocking Strategic Investment Opportunities in the Pharmaceutical Industry As we navigate the ever-evolving landscape of the pharmaceutical industry, one thing remains constant: the expiration of patents on blockbuster medications. These expirations can have a significant impact on the market, creating opportunities for strategic investment and growth.
NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being prescribed. Yet both he and University of Pennsylvania researcher Kiran Musunuru are forging ahead, using contrasting approaches, as they explained onstage at STAT’s Breakthrough Summit East.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy successfully conducted Session 17 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, delivering comprehensive guidance on gap analysis and implementation plan for revised Schedule M compliance. The 3.5-hour workshop provided participants with direction, supplementary documentation, and hands-on learning, ensuring they were well-equipped to meet compliance requirements.
Todays guest post comes from Greg Skalicky, President of EVERSANA. Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). He introduces us to EVERSANA DIRECT Commercialization, a direct-to-patient change/model. To learn more about EVERSANA DIRECT Commercialization and how the direct-to-patient model can help you, meet with EVERSANA at the Asembia Summit in Las Vegas
Unlock the Full Potential of Your Pharmaceutical Product: The Power of a CDMO As a pharmaceutical professional, you're constantly looking for ways to bring innovative products to market faster and more efficiently. One key strategy that can help you achieve this goal is partnering with a Contract Development and Manufacturing Organization (CDMO). But what exactly is a CDMO, and how can it benefit your business?
On Friday, medical students around the U.S. will learn what residency program they have matched into. Match Day is not just momentous for those students, though. It also tells the rest of us what fields of medicine are having trouble attracting new physicians. In 2024, about 8% of pediatrics positions went unfilled , an increase from about 3% in 2023.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Tech Mahindra announced a pharmacovigilance (PV) autonomous solution built with NVIDIA AI software to advance drug safety management. The solution leverages agentic artificial intelligence (AI) and automation to enhance the accuracy, speed, and efficiency of pharmacovigilance processes, addressing critical industry challenges such as manual delays and data overload.
Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.
Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Sovereign Pharma, gains EU approval for aseptic and terminally sterilised products, including vials, ampoules, cartridges, and pre-filled syringes (PFS) for both liquid and lyophilized formulations. This achievement is a significant step in the companys commitment to quality, safety, and global healthcare excellence. In addition to the EU approval, ANVISA, the regulatory body under Brazils Ministry of Health, granted approval for aseptically processed and terminally sterilised small volume paren
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There’s sure to be a lot of news coming out of the Breakthrough Summit East today, which is taking place just a few blocks away from my favorite Shake Shack in Manhattan. In-person tickets are sold out, but you can still snag a virtual ticket here.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The National Health Service (NHS) in England has approved Gedeon Richters Ryeqo, the first long-term pill available for endometriosis for patients who have exhausted all other treatment options. The approval addresses the long-standing gap in long-term treatment options for endometriosis, improving overall disease management while easing the burden on healthcare resources, says GlobalData.
By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.
An antibody treatment from Immunovant and Roivant Sciences significantly reduced symptoms and disease activity in patients with generalized myasthenia gravis, a debilitating autoimmune disease — achieving the goals of a Phase 3 clinical trial, the companies reported Wednesday. In the study, patients treated with low and high doses of the drug, called batoclimab, showed 4.7-point and 5.6-point improvements, respectively, on a patient-reported symptoms and activity scale called MG-ADL
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets, 75 mg and 100 mg (USRLD: Viberzi Tablets, 75 mg and 100 mg). Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS-D). Eluxadoline tablets will be produced at Zydus Lifesciences (SEZ), Ahmedabad.
Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.
UK pharma group acquires Belgiums EsoBiotec as it announces EU has approved Imfinzi lung cancer drug Business live latest updates AstraZeneca has struck a $1bn (773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions that also yielded positive results for a late-stage rare disease drug on Monday.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content